EMG
ALNY icon

Ellington Management Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Ellington Management Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,500
Closed -$925K – 55
2020
Q1 		$925K Buy
+8,500
New +$981K 0.27% 122
2019
Q2 		– Sell
-4,800
Closed -$449K – 565
2019
Q1 		$449K Buy
4,800
+700
+17% +$58.5K 0.1% 256
2018
Q4 		$299K Buy
+4,100
New +$315K 0.11% 225
2017
Q3 		– Sell
-5,900
Closed -$471K – 613
2017
Q2 		$471K Buy
+5,900
New +$377K 0.13% 258
2014
Q2 		– Sell
-9,300
Closed -$624K – 439
2014
Q1 		$624K Buy
+9,300
New +$720K 0.18% 158

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return